BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 7405336)

  • 1. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperkeratotic variant of Darier's disease. Successful oral treatment using an aromatic retinoid (Ro 10-9395)].
    Hönigsmann H; Fritsch P; Jaschke E
    Hautarzt; 1978 Nov; 29(11):601-3. PubMed ID: 721466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dyskeratosis follicularis Darier with the retinoic acid derivative Ro 10-9359 (Tigason).
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1981; 163(2):164-8. PubMed ID: 7286356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
    Frenk E
    Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Darier's disease with an oral aromatic retinoid (Ro 10-9359): a clinical and light and electron microscopic study.
    Lauharanta J; Niemi KM; Lassus A
    Acta Derm Venereol; 1981; 61(6):535-42. PubMed ID: 6177166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of follicular dyskeratosis (Darier's disease) with aromatic vitamin A].
    Mária W; Miklós S
    Orv Hetil; 1981 Mar; 122(9):522-4. PubMed ID: 7290698
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic efficacy of tigazon in treating dermatoses].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Kriazheva SS; Butov IuS
    Vestn Dermatol Venerol; 1990; (5):4-6. PubMed ID: 2402940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359).
    Kariniemi AL; Stubb S; Lassus A
    Br J Dermatol; 1980 Feb; 102(2):213-4. PubMed ID: 7387874
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic use of an aromatic derivative of vitamin A acid (Ro 10-9359) in psoriasis and keratosis].
    Schimpf A
    Z Hautkr; 1976 Apr; 51(7):265-75. PubMed ID: 134523
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of congenital erythroderma ichthyosiforme in mother and son with the oral aromatic retinoid Ro 10-9359. The need for maintenance therapy].
    Mashkilleysson AL; Mashkilleysson NA
    Z Hautkr; 1983 Aug; 58(15):1127-9. PubMed ID: 6415945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment of a number of disorders in the keratinization of the skin using an aromatic retinoid (Ro 10-9359)].
    Notowicz A; Vermeiden I; Stolz E
    Ned Tijdschr Geneeskd; 1980 Aug; 124(31):1286-90. PubMed ID: 7412901
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment with an oral aromatic retinoid in linear porokeratosis.
    Pehamberger H; Konrad K
    Dermatologica; 1980; 160(4):270-4. PubMed ID: 7358191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral retinoid (Ro 10-9359) in children with lamellar ichthyosis, epidermolytic hyperkeratosis and symmetrical progressive erythrokeratoderma.
    Tamayo L; Ruiz-Maldonado R
    Dermatologica; 1980; 161(5):305-14. PubMed ID: 6449393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 18. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH
    S Afr Med J; 1983 Jul; 64(2):54-6. PubMed ID: 6867876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment of keratosis follicularis with a new aromatic retinoid.
    Orfanos CE; Kurka M; Strunk V
    Arch Dermatol; 1978 Aug; 114(8):1211-4. PubMed ID: 677921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Darier's disease and renal polycystosis. Familial study and effects of aromatic retinoid].
    Claudy A; Toulon J; Dutoit M; Sabatier JC; Berthoux FC
    Ann Dermatol Venereol; 1981; 108(8-9):675-7. PubMed ID: 7316395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.